Abstract

Cholesterol metabolism plays a critical role in the progression of hepatocellular carcinoma (HCC), but it is not clear how cholesterol metabolism is regulated. The tubulin beta class I genes (TUBBs) are associated with the prognosis of many different cancers. To confirm the function of TUBBs in HCC, the Kaplan–Meier method and Cox analyses were performed using TCGA and GSE14520 datasets. A higher expression of TUBB2B is an independent prognostic factor for shorter over survival in HCC patients. Deletion of TUBB2B in hepatocytes inhibits proliferation and promotes tumor cell apoptosis, while over-expression of TUBB2B has the opposite function. This result was confirmed in a mouse xenograft tumor model. Mechanistically, TUBB2B induces the expression of CYP27A1, an enzyme responsible for the conversion of cholesterol to 27-hydroxycholesterol, which leads to the up-regulation of cholesterol and the progression of HCC. In addition, TUBB2B regulates CYP27A1 via human hepatocyte nuclear factor 4alpha (HNF4A). These findings indicated that TUBB2B functions as an oncogene in HCC, and plays a role in promoting cell proliferation and anti-apoptosis through targeting HNF4A/CYP27A1/cholesterol.

Details

Title
TUBB2B facilitates progression of hepatocellular carcinoma by regulating cholesterol metabolism through targeting HNF4A/CYP27A1
Author
Wang, Xiaobo 1   VIAFID ORCID Logo  ; Shi, Jiawei 2 ; Huang, Mingming 3 ; Chen, Jiehong 4 ; Dan, Jia 3 ; Tang, Yunhua 3 ; Guo, Zhiyong 3   VIAFID ORCID Logo  ; He, Xiaoshun 3   VIAFID ORCID Logo  ; Zhao, Qiang 3 

 Southern Medical University, Department of Spinal Surgery, Nanfang Hospital, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); Sun Yat-Sen University, Organ Transplant Center, the First Affiliated Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X); Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China (GRID:grid.484195.5); Guangdong Provincial International Cooperation Base of Science and Technology, Guangzhou, China (GRID:grid.484195.5) 
 Southern Medical University, Department of Spinal Surgery, Nanfang Hospital, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471) 
 Sun Yat-Sen University, Organ Transplant Center, the First Affiliated Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X); Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China (GRID:grid.484195.5); Guangdong Provincial International Cooperation Base of Science and Technology, Guangzhou, China (GRID:grid.484195.5) 
 Sun Yat-sen University, Department of Pharmacology, Zhongshan School of Medicine, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
Pages
179
Publication year
2023
Publication date
Mar 2023
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2782844757
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.